Zhongchao Operating Income 2019-2023 | ZCMD
Zhongchao operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Zhongchao Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-13 |
| 2022 | $-3 |
| 2021 | $-0 |
| 2020 | $4 |
| 2019 | $4 |
| 2018 | $3 |
| Zhongchao Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.019B |
| Zhongchao Inc. is a provider of healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform. Zhongchao Inc. is headquartered in Beijing, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.800B | 20.21 |
| Inspire Medical Systems (INSP) | United States | $4.798B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.473B | 0.00 |
| Axonics (AXNX) | United States | $3.450B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.982B | 0.00 |
| 10x Genomics (TXG) | United States | $2.868B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.818B | 0.00 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Azenta (AZTA) | United States | $2.749B | 154.58 |
| Privia Health (PRVA) | United States | $1.962B | 109.60 |
| Schrodinger (SDGR) | United States | $1.646B | 0.00 |
| Omnicell (OMCL) | United States | $1.481B | 51.17 |
| Phreesia (PHR) | United States | $1.301B | 0.00 |
| Standard BioTools (LAB) | United States | $0.958B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.668B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.506B | 0.00 |
| Talkspace (TALK) | United States | $0.468B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
| Pulmonx (LUNG) | United States | $0.347B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.307B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
| Outset Medical (OM) | United States | $0.202B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.47 |
| 111 (YI) | China | $0.107B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.100B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |